CN107445994A — 替诺福韦艾拉酚胺半富马酸盐新晶型
Assigned to Beijing Fukangren Bio Pharm Tech Co Ltd · Expires 2017-12-08 · 8y expired
What this patent protects
替诺福韦艾拉酚胺半富马酸盐新晶型，本发明涉及一种替诺福韦艾拉酚胺半富马酸盐，化学名称为((S)‑((((R)‑1‑(6‑氨基‑9H‑嘌呤‑9‑基)丙烷‑2‑基)氧基)甲基)(苯氧基)膦酰基)‑L‑丙氨酸异丙酯半富马酸盐的新晶型(晶型B)，包含此晶型的药物制剂，它们的治疗用途及其制备方法；该新晶型在高温、高湿等条件下稳定，易于规模化制备，具有较好的应用前景。
USPTO Abstract
替诺福韦艾拉酚胺半富马酸盐新晶型，本发明涉及一种替诺福韦艾拉酚胺半富马酸盐，化学名称为((S)‑((((R)‑1‑(6‑氨基‑9H‑嘌呤‑9‑基)丙烷‑2‑基)氧基)甲基)(苯氧基)膦酰基)‑L‑丙氨酸异丙酯半富马酸盐的新晶型(晶型B)，包含此晶型的药物制剂，它们的治疗用途及其制备方法；该新晶型在高温、高湿等条件下稳定，易于规模化制备，具有较好的应用前景。
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.